Related Experiment Video
Updated: May 8, 2026
Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation
Published on: May 22, 2017
Mimicry of high-density lipoprotein: functional peptide-lipid nanoparticles based on multivalent peptide constructs
Yannan Zhao1, Tomohiro Imura, Luke J Leman
1Department of Chemistry, ‡Department of Immunology and Microbial Science, and §The Skaggs Institute for Chemical Biology, The Scripps Research Institute , 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Engineered peptide-lipid nanoparticles mimic high-density lipoprotein (HDL) function. These novel HDL-like particles efficiently remodel native HDLs, promote cholesterol efflux, and significantly reduce plasma cholesterol in mice, offering a promising atherosclerosis treatment strategy.
Area of Science:
- Biochemistry
- Nanotechnology
- Cardiovascular Research
Background:
- High-density lipoprotein (HDL) plays a crucial role in reverse cholesterol transport.
- Engineering synthetic HDL-like particles is a therapeutic strategy for atherosclerosis.
- Previous attempts using monomeric peptides have shown limitations in stability and efficacy.
Purpose of the Study:
- To design and synthesize novel peptide-lipid nanoparticles that mimic HDL functionality.
- To evaluate the in vitro and in vivo performance of these engineered nanoparticles.
- To assess the potential of these nanoparticles as a therapeutic agent for atherosclerosis.
Main Methods:
- Design and synthesis of branched, multivalent peptide constructs.
- Formation of nanometer-scale discoidal HDL-like particles with phospholipids.
- Characterization using size exclusion chromatography, analytical ultracentrifuge sedimentation, circular dichroism, transmission electron microscopy, and fluorescence spectroscopy.
- In vitro and in vivo functional assays including cholesterol efflux and plasma remodeling.
- Pharmacokinetic studies and efficacy assessment in LDLr-null mice.
Main Results:
- Successfully engineered stable, HDL-like peptide-lipid nanoparticles.
- Nanoparticles remodeled native HDLs and promoted efficient cellular cholesterol efflux.
- Multivalent peptide nanoparticles demonstrated superior function compared to monomeric peptide-based particles.
- In vivo studies showed favorable pharmacokinetics, long half-lives, and stability against enzymatic digestion.
- A two-week study in LDLr-null mice resulted in a 50% reduction in plasma total cholesterol.
Conclusions:
- Multivalent peptide-lipid nanoparticles represent a promising synthetic HDL mimetic.
- These nanoparticles offer enhanced stability and superior cholesterol-modulating capabilities.
- The findings support the potential of these engineered nanoparticles for atherosclerosis treatment.
